Scandinavian Medical Solutions A/S (CPH:SMSMED)
Denmark
· Delayed Price · Currency is DKK 5.00
+0.11 (2.25%)
May 13, 2025, 11:58 AM CET
CPH:SMSMED Revenue
In the fiscal year ending September 30, 2024, Scandinavian Medical Solutions had annual revenue of 226.68M DKK with 18.56% growth. Scandinavian Medical Solutions had revenue of 124.12M in the half year ending September 30, 2024, with 112.00% growth.
Revenue
226.68M
Revenue Growth
+18.56%
P/S Ratio
0.59
Revenue / Employee
8.72M
Employees
26
Market Cap
134.48M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 226.68M | 35.49M | 18.56% |
| Sep 30, 2023 | 191.19M | 80.66M | 72.98% |
| Sep 30, 2022 | 110.53M | 38.89M | 54.29% |
| Sep 30, 2021 | 71.64M | 29.69M | 70.78% |
| Sep 30, 2020 | 41.95M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 303.14B |
| Coloplast | 27.79B |
| Genmab | 21.64B |
| Demant | 22.42B |
| ALK-Abelló | 5.71B |
| Zealand Pharma | 55.69M |
| H. Lundbeck | 22.00B |
| Ambu A/S | 5.83B |